AU545685B2 - Method of treating cerebrovascular insufficiency - Google Patents

Method of treating cerebrovascular insufficiency

Info

Publication number
AU545685B2
AU545685B2 AU64603/80A AU6460380A AU545685B2 AU 545685 B2 AU545685 B2 AU 545685B2 AU 64603/80 A AU64603/80 A AU 64603/80A AU 6460380 A AU6460380 A AU 6460380A AU 545685 B2 AU545685 B2 AU 545685B2
Authority
AU
Australia
Prior art keywords
treating cerebrovascular
cerebrovascular insufficiency
insufficiency
treating
cerebrovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU64603/80A
Other languages
English (en)
Other versions
AU6460380A (en
Inventor
Peter Neumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU6460380A publication Critical patent/AU6460380A/en
Application granted granted Critical
Publication of AU545685B2 publication Critical patent/AU545685B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU64603/80A 1979-11-23 1980-11-21 Method of treating cerebrovascular insufficiency Expired AU545685B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7940624 1979-11-23
GB7940624 1979-11-23

Publications (2)

Publication Number Publication Date
AU6460380A AU6460380A (en) 1981-05-28
AU545685B2 true AU545685B2 (en) 1985-07-25

Family

ID=10509391

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64603/80A Expired AU545685B2 (en) 1979-11-23 1980-11-21 Method of treating cerebrovascular insufficiency

Country Status (4)

Country Link
JP (1) JPS5687522A (cs)
AU (1) AU545685B2 (cs)
BE (1) BE886259A (cs)
IT (1) IT1128630B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545075B2 (cs) * 1973-11-29 1980-11-15
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1105477A (en) * 1976-03-22 1981-07-21 Edwin J. Quinn Structurally regulated polyphosphazene copolymers
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
JPS5844066B2 (ja) * 1978-06-16 1983-09-30 釜屋化学工業株式会社 輸液瓶の製造方法

Also Published As

Publication number Publication date
BE886259A (fr) 1981-05-20
IT8050217A0 (it) 1980-11-21
IT1128630B (it) 1986-05-28
AU6460380A (en) 1981-05-28
JPH0138088B2 (cs) 1989-08-11
JPS5687522A (en) 1981-07-16

Similar Documents

Publication Publication Date Title
AU572938B2 (en) Method of treating endometriosis or dysmenorrhea
JPS54143691A (en) Method of lightttoosound spectroscopy
JPS5659610A (en) Method of treating aluminocalcium phosphate
PH20118A (en) Method for the treatment of hyperlemia
JPS5533791A (en) Method of treating plasma of substance
ZA786811B (en) Method of treating hypertension
JPS5695604A (en) Method of treating veneer
AU545685B2 (en) Method of treating cerebrovascular insufficiency
JPS5663808A (en) Method of adjusting reeafterrprecipitation
SU661041A1 (ru) Способ обработки из делий из инварных сплавов
JPS5613934A (en) Method of treating xxray picture
JPS5618487A (en) Method of regulating split substrate
JPS55102293A (en) Method of fixing component
JPS5687786A (en) Method of dehydrating veneer
SU608840A2 (ru) Способ обработки изделий
JPS5616796A (en) Method of backkfilling
JPS5595752A (en) Method of heattinsulating roof
JPS55132300A (en) Method of pasting cover
JPS5665444A (en) Method of uniformly irradiating surface
JPS55252A (en) Method of treating standarddlength veneer
JPS5664399A (en) Method of controlling piezoelectriccbuzzer sounddpressure
BG32341A1 (en) Method for treating of glass articless
JPS56101147A (en) Method of treating photgraphic layer
JPS557498A (en) Method of treating veneer
JPS5692002A (en) Method of treating veneer

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired